BioLargo, Inc. (BLGO) Shareholder/Analyst Call Transcript
BioLargo, Inc. (BLGO) Q4 2025 Earnings Call Transcript
BioLargo Installs AEC PFAS Treatment System at Lake Stockholm, New Jersey
BioLargo to Present at Sidoti's Micro-Cap Virtual Conference on Thursday January 22nd at 1pm EST
BioLargo Reflects on 2025 Progress and Positions for the Next Phase of Global Infrastructure, Environmental, and Medical Innovation
BioLargo Subsidiary BEST Featured in Chemical Engineering Magazine for PFAS Breakthrough
BioLargo to Present at NobleCon's 21st Annual Emerging Growth Equity Conference, Dec. 2-3, 2025
BioLargo Reports Q3 2025 Operating and Financial Results
BioLargo, Inc. (BLGO) Q3 2025 Earnings Call Transcript
BioLargo Inc (BLGO) Q3 2025 Earnings Call Highlights: Strategic Partnerships and ...
BioLargo Q3 2025 Earnings Results Webcast and Conference Call on Friday, November 14th, 2025 - 4:30 PM Eastern Time
BioLargo Subsidiary Clyra Medical Technologies Forms Strategic Alliance with Advanced Solution to Launch ViaCLYR(TM) Wound Irrigation Solution Nationwide
BioLargo Files Federal Lawsuit Against Pooph Inc.
BioLargo Cuts AEC PFAS Treatment Energy Use by >90%, Unlocking Commercial-Scale Water Solutions with Unmatched Total Life Cycle Cost Savings
BioLargo Presentation Deck at LD Micro Event Available Online
Biolargo Invites You to the Sustain SoCal 16th Annual Energy Event - A Premier Gathering for Clean Energy Innovation
BioLargo to Present Its Cellinity Battery Technology at LD Micro Main Event XIX in San Diego on Monday, October 20, at 2:00 p.m. PT
BioLargo Subsidiary Clyra Medical Accelerates Toward Near-Term Product Launches and Global Expansion
BioLargo Protects Its Intellectual Property That Built a National Brand - Pooph's License Was Revoked for Non-Payment and Unauthorized Activities
BioLargo Demonstrates Over 99% Removal of Ultrashort-Chain PFAS Including TFA Using Aqueous Electrostatic Concentration Technology
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.